News

B-cells and Antibodies – B-cells make antibodies, which help your body recognise and fight infections. Smoking reduces the number of these cells and weakens their function. This means your body is ...
DelveInsight’s Natural Killer (NK)-Cell Lymphoma Pipeline report depicts a robust space with 100+ active players working to develop 140+ pipeline therapies for Natural Killer (NK)-Cell Lymphoma ...
Tissue-specific immune memory has become a central focus in immunology, drawing attention to the distinct roles of tissue-resident memory lymphocytes, their ...
In the current study, the scientists thought NK cells might also have a direct impact on the brain chemicals that modulate ...
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that members of its executive team will present and host 1x1 meetings at the upcoming ...
Innate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research ...
Long term follow-up data from the TELLOMAK Phase 2 trial in Sézary syndrome (SS) and mycosis fungoides (MF) will be presented at the ASCO Annual Meeting 2025. Long-term follow-up data from ...
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced the voting ...
As part of the event, Dr. Hertz will provide a corporate overview and business outlook. In addition to the moderated ...
LIfT BioSciences presents latest data on its first-in-class Immunomodulatory Alpha Neutrophils at International Society for ...
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced today that four abstracts with Innate's drugs in clinical development have been accepted for the American ...
Replimune Group shares fell 28% on heavy volume with no news, despite a promising July 2025 PDUFA date for RP1 in advanced melanoma. Read the latest REPL stock analysis here.